SONOVAL LLC
BALTIMORE, United States · Founded 2020
- Headquarters
- BALTIMORE, Maryland
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- sonoval.com
- Last Round
- GrantJan 2019
- Rounds
- 3
About
Sonoval is a biopharmaceutical company developing protein-based anticancer therapies for T-cell lymphomas and solid tumors. Its lead candidate SON-211 is an IL-2-diphtheria toxin fusion protein that destroys cancer cells expressing the CD25 receptor while also eliminating immune suppressors to unleash the patient's own anticancer defenses. The company is based at the University of Maryland BioPark in Baltimore.
Summary
SONOVAL LLC is a Biotech company based in BALTIMORE, United States, founded in 2020. Its most recent funding was a Grant round in Jan 2019. Investors include TEDCO.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.